Trulieve Cannabis Corp. reported a slight decline in revenue for the fiscal year ending December 31, 2025, generating $1.18 billion, down 0.4% from $1.19 billion in 2024. The decrease was primarily attributed to an $18.4 million drop in retail revenue, which was partially offset by a $13.1 million increase in wholesale and other revenue. The company noted that the increase in wholesale revenue was driven by new partnerships in states like Maryland, Ohio, and Pennsylvania, while retail revenue was impacted by price compression despite higher customer traffic and units sold.
In terms of profitability, Trulieve's gross profit also saw a minor decline, falling to $711.2 million from $715.7 million in the previous year. The cost of goods sold remained relatively stable at $470 million, resulting in a gross margin of 60.2%. The company successfully reduced its selling, general, and administrative expenses by 12.8%, totaling $445.2 million, which contributed to a significant increase in income from operations to $143.5 million, a 46.8% rise compared to the prior year.
Strategically, Trulieve has been active in expanding its operations and optimizing its financial structure. In December 2025, the company completed the redemption of its outstanding 8.0% Senior Secured Notes due 2026, totaling $368 million, and fully repaid its Blue Ridge Bank mortgage note. Additionally, Trulieve closed a private placement of 10.5% Senior Secured Notes due 2030, raising approximately $140 million, which will be used for capital expenditures and general corporate purposes. The company also received conditional approval for a dispensing organization license in Texas, which is pending final regulatory approval.
Operationally, Trulieve maintained a strong presence with 233 dispensaries across nine states, including 162 in Florida and 22 in Arizona. The company reported a workforce of over 5,000 employees, reflecting its commitment to growth and customer service. The filing indicated that Trulieve's customer engagement strategies, including educational events and community partnerships, have been effective in fostering brand loyalty and expanding its customer base.
Looking ahead, Trulieve remains optimistic about its growth prospects, particularly with the potential reclassification of cannabis to Schedule III under the Controlled Substances Act, which could enhance market conditions and facilitate further expansion. The company plans to continue investing in its infrastructure and technology to support its operations and maintain its competitive edge in the evolving cannabis market.
About Trulieve Cannabis Corp.
Trulieve Cannabis Corp. is a vertically integrated multi-state operator in the U.S. cannabis industry, focusing on cultivation, manufacturing, and retail of high-quality medical and adult-use cannabis products. It operates in nine states with a large retail footprint, proprietary brands, and a focus on customer experience. The company emphasizes product quality, regulatory compliance, and expanding access through its distribution network and branded offerings.
About 10-K Filings
A 10-K form is a comprehensive annual report that public companies in the United States must file with the SEC, providing a detailed overview of the company's financial condition, performance, and business strategies.
Key points about the 10-K:
- Frequency: Filed annually, typically within 60 to 90 days after the end of the company's fiscal year.
-
Content: It includes:
- Detailed financial statements audited by an independent accounting firm
- Management's Discussion and Analysis (MD&A) of financial condition and results
- Description of the company's business, properties, and legal proceedings
- Risk factors and market risks
- Executive compensation and corporate governance information
- Importance: Considered the most comprehensive and important document a public company files with the SEC.
- Length: Often exceeds 100 pages due to its extensive and detailed nature.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.